Communiqués Waldencast plc

Actions

WALD

JE00BPG99318

Détaillants autres spécialités

Temps réel estimé Cboe BZX 20:31:21 24/09/2026			Varia. 5j.	Varia. 1 janv.
1,035 ^USD	0,00%		-9,21%	-44,95%

14/09	Les plus fortes baisses en avant-Bourse	MT
14/09	Waldencast prévoit un retrait volontaire de la cote du Nasdaq ; le titre chute en avant-bourse	MT

Communiqués

15/06	Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel	AQ
15/05	Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting	AQ
16/11	Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting	AQ
12/11	Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates	AQ
10/06/25	Waldencast : Q1 2025 Transcript	PU
14/05/25	Waldencast : Q1 2025 Earnings Presentation	PU
20/03/25	Waldencast : Q4 2024 Transcript	PU
18/03/25	Waldencast : Q4 2024 Earnings Presentation	PU
11/03/25	Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast	AQ
20/11/24	Waldencast : Reports Q3 2024 Financial Results Form 6 K	PU
20/11/24	Waldencast : Amendment to Annual Report by Foreign Issuer Form 20 F/A	PU
13/11/24	Waldencast : Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast Form 6 K	PU
30/10/24	Waldencast : Information in this Report Form 6 K	PU
07/10/24	Waldencast plc Announces Board Appointments and Annual General Meeting	AQ
07/10/24	Waldencast : Announces Board Appointments and Annual General Meeting Form 6 K	PU
21/08/24	Waldencast plc Provides Second Quarter and First Half Fiscal 2024 Earnings Conference Call and Webcast Information	AQ
27/06/24	Waldencast : Announces Upcoming Earnings Release and Conference Call Dates Form 6 K	PU
21/05/24	Waldencast : Reports Q1 2024 Financial Results - Form 6-K	PU
13/05/24	Waldencast : Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast - Form 6-K	PU
01/05/24	Waldencast Announces Participation in CreatorIQ Connect Europe	AQ
30/04/24	Waldencast : Reports Fiscal Year 2023 Financial Results - Form 6-K	PU
25/03/24	Waldencast Regains Compliance with Nasdaq Filing Requirements	AQ
21/03/24	Johnson Fistel, LLP is Investigating Waldencast for Violation of Securities Laws; WALD, WALDW	BU
21/03/24	Waldencast : OBAGI GLOBAL HOLDINGS LIMITED - Form 6-K	PU
07/03/24	Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream	AQ